MIRaGE (Minimally Invasive suRGery in recurrent Endometrial cancer)
Minimally invasive surgery may represent a feasible option for selected patients with recurrent endometrial cancer, providing perioperative advantages with comparable survival outcomes. Prospective multicenter studies are needed to confirm oncologic safety and to refine patient selection, also in the context of integration with novel therapies.
Authors
- Silvia Bottazzi (ORCID: https://orcid.org/0009-0003-7594-898X)
- Virginia Vargiu (ORCID: https://orcid.org/0000-0003-4954-719X)
- Vito Andrea Capozzi (ORCID: https://orcid.org/0000-0003-4720-5663)
- Roberto Berretta (ORCID: https://orcid.org/0000-0003-2324-5409)
- Lucia Tortorella (ORCID: https://orcid.org/0000-0001-5271-3051)
- Emanuele Perrone (ORCID: https://orcid.org/0000-0002-0938-2493)
- Francesco Cosentino (ORCID: https://orcid.org/0000-0002-5698-7946)
- Andrea Rosati (ORCID: https://orcid.org/0000-0003-3126-9400)
- Camilla Certelli (ORCID: https://orcid.org/0000-0002-8325-6946)
- Anna Fagotti (ORCID: https://orcid.org/0000-0001-5579-335X)
- Diana Giannarelli (ORCID: https://orcid.org/0000-0002-6085-1195)
- Valerio Gallotta (ORCID: https://orcid.org/0000-0003-4254-9379)
- Francesco Fanfani (ORCID: https://orcid.org/0000-0002-4354-5735)
- Martina Corrado
- Maria Consiglia Giuliano
Institutions
- Università Cattolica del Sacro Cuore (IT)
- University of Parma (IT)
- University of Molise (IT)
- Agostino Gemelli University Polyclinic (IT)
Publication Details
- Journal
- International Journal of Gynecological Cancer
- Published
- 2025-10-11
- DOI
- https://doi.org/10.1016/j.ijgc.2025.102726
- Citations
- 1
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.06